AQUAVAC PD3 is a trivalent vaccine (0.1 ml dose) containing inactivated Salmon pancreas disease virus (SPDV) strain F93-125, Infectious Pancreatic Necrosis virus (IPNV) and Aeromonas salmonicida.
White to nearly white emulsion for injection
Salmon pancreas disease virus (SPDV) strain F93-125, ≥ 75 % RPP1
Infectious pancreatic necrosis virus (IPNV), ≥ 1.5 ELISA units2
Aeromonas salmonicida subsp. salmonicida, ≥ 80 % RPS602
1 RPP: relative percentage protection in a laboratory test in Atlantic salmon
2 Antigenic mass measured in the final product
3 RPS: relative percentage survival at 60 % control mortality in a laboratory test in Atlantic salmon
Indications for use
For active immunisation of Atlantic Salmon to reduce clinical signs (heart lesions and pancreas lesions), viremia, viral shedding and mortality from infection with SPDV (Pancreas disease) and to reduce mortality from infections with IPNV (Infectious pancreatic necrosis) and Aeromonas salmonicida subsp. salmonicida (furunculosis).
Immunity is onset 500 degree days after vaccination for SPDV and Aeromonas salmonicida and 540 degree days after vaccination for IPNV.
Duration of immunity has been demonstrated at 15 months post vaccination for SPDV and at 16 months post vaccination for Aeromonas salmonicida. Protection against mortality due to IPNV infection has been demonstrated at 4 months post vaccination in the field.
Zero degree days
Bottles of polyethylene terephthalate (PET) closed with a rubber stopper and aluminium cap. Package size: 500 ml (5,000 doses).
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018